28 research outputs found

    Zooterapia amazônica: uso de gordura de sucuri ( Eunectes murinus ) como cicatrizante natural

    Get PDF
    Zootherapy (the use of the therapeutic potential of animals) is at least 6,000 years old, and has been kept active throughout generations until modern days. Animal fat is commonly used in the zootherapeutic folk medicine from South America, specially the green anaconda's fat, which is widely promoted as a natural medicine to treat wounds, even though there is no scientific evidence showing its efficacy. In this study we compared the total healing time and the proportional daily reduction of dorsal epithelial incisions in adult male Wistar rats treated with nitrofural (a commercial cicatrizing ointment) and with anaconda fat. We applied the treatments every two days and measured the incision diameter daily, during ten consecutive days. Differences among the groups in the total healing time and in the proportional daily reduction of the incision consistently showed that the fat-based treatment resulted in a faster healing process compared to the commercial ointment tested. The literature suggests that the efficacy of animal fat on healing may be primarily related to the presence of fatty acids, which have been widely demonstrated to be important for biochemical reactions involved in healing processes. Our findings are widely socially relevant, considering that traditional Amazonian communities that use anaconda fat in folk medicine do not have easy access to pharmacies and hospitals.Práticas ancestrais de zooterapia (uso das potencialidades terapêuticas da fauna) existem há pelo menos 6000 anos, e têm sido mantidas ao longo de gerações até os tempos modernos. Gordura de animais é comumente utilizada na zooterapia tradicional da América do Sul, e a gordura de serpentes sucuris é amplamente comercializada como cicatrizante natural, embora não existam evidências científicas que mostrem sua eficácia terapêutica. Neste estudo comparamos o tempo de cicatrização epitelial total e a redução proporcional diária de uma incisão dorsal em ratos Wistar machos adultos, entre um grupo controle, um grupo tratado com nitrofural (uma pomada cicatrizante comercial) e um grupo tratado com gordura de sucuri. Nós aplicamos os tratamentos a cada dois dias e medimos o diâmetro da incisão diariamente por dez dias consecutivos. Diferenças entre os grupos no tempo de cicatrização total e na redução proporcional diária da incisão consistentemente mostraram que gordura de sucuri teve ação cicatrizante mais eficiente que a pomada comercial testada. A literatura sugere que a eficácia de gordura animal em processos de cicatrização pode estar principalmente relacionada à presença de ácidos graxos, os quais têm sido amplamente demonstrados como importantes para reações bioquímicas envolvidas em processos de cicatrização. Os resultados têm ampla relevância social, considerando que as comunidades tradicionais amazônicas que utilizam a gordura de sucuris como zooterápico não têm acesso fácil a farmácias e hospitais

    Lower-extremity Arteriovenous Access for Haemodialysis: A Systematic Review

    Get PDF
    Background: The lower extremity is increasingly used as an access site in end-stage renal disease patients. However, reports present conflicting results, creating confusion regarding the feasibility and outcomes. Our objective is to review the available Literature and analyse the patency rates and complications of various types of lower-extremity arteriovenous access. Methods: An Internet-based literature search was performed using MEDLINE to identify all published reports on lower-extremity vascular access. The analysis involved studies comprising at least 10 arteriovenous accesses with both inflow and outflow vessels in the lower extremity, and reporting on patency rates and access-related complications. The weighted mean patency rates were calculated, and the chi-square (chi(2)) test was used to evaluate the differences in the complication rates in the subgroups of patients identified. Results: Three main types of lower-extremity vascular access were identified: the upper thigh prosthetic, the mid-thigh prosthetic and the femoral vein transposition arteriovenous access. There are limited data on saphenous vein loop grafts, which report poor results. The weighted mean primary patency rates at 12 months were 48%, 43% and 83%, respectively. The weighted mean secondary patency rates at 12 months were 69%, 67% and 93%, respectively. Access loss as a result of infection was more common in upper thigh and mid-thigh grafts than femoral vein transposition arteriovenous access (18.40%, 18.33% vs. 1.61%; P < 0.05). Ischaemic complications rates were higher in autologous than prosthetic arteriovenous access (20.97% vs. 7.18%, P < 0.05). Conclusions: Lower-extremity vascular access has acceptable results in terms of patency, with femoral vein transposition having better patency rates than femoral grafts. Autologous access is associated with less infective complications, however, at the expense of increased ischaemic complications rates. Further research with randomised trials is required to assess the outcomes of lower-extremity vascular access. (C) 2009 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery
    corecore